Nektar to Announce Financial Results for the Third Quarter 2023 on Tuesday, November 7, 2023, After Close of U.S.-Based Financial Markets

Rhea-AI Summary

Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2023 on November 7, 2023. The conference call to review the results will be hosted by Howard Robin, President and CEO, at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time. The press release and webcast can be accessed through the Nektar website. The webcast will be available for replay until December 8, 2023.

SAN FRANCISCO, Oct. 31, 2023 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2023 on Tuesday, November 7, 2023, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

The press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: http://ir.nektar.com/. The web broadcast of the conference call will be available for replay through December 8, 2023.

To access the conference call, please pre-register at Nektar Earnings Call Registration. All registrants will receive dial-in information and a PIN allowing them to access the live call.

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in immunology and oncology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional manufacturing operations in Huntsville, Alabama. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contact:

For Investors:

Vivian Wu of Nektar Therapeutics
628-895-0661

For Media:

David Rosen of Argot Partners
(212) 600-1902
david.rosen@argotpartners.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-third-quarter-2023-on-tuesday-november-7-2023-after-close-of-us-based-financial-markets-301973407.html

SOURCE Nektar Therapeutics

FAQ

When will Nektar Therapeutics announce its financial results for the third quarter 2023?

Nektar Therapeutics will announce its financial results for the third quarter 2023 on November 7, 2023.

Who will host the conference call to review the results?

Howard Robin, President and Chief Executive Officer, will host the conference call to review the results.

What time will the conference call begin?

The conference call will begin at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.

Where can I access the press release and webcast?

The press release and live audio-only webcast can be accessed through a link on the Nektar website.

How long will the webcast be available for replay?

The webcast will be available for replay until December 8, 2023.